175 related articles for article (PubMed ID: 2860271)
1. Adverse effect of intrapleural Corynebacterium parvum as adjuvant therapy in resected stage I and II non-small cell carcinoma of the lung. Ludwig Lung Cancer Study Group.
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):842-7. PubMed ID: 2860271
[TBL] [Abstract][Full Text] [Related]
2. [Postoperative prevention of recurrence with intrapleural Corynebacterium parvum in patients with stage I and II bronchial carcinomas. Ludwig lung cancer study I].
Schweiz Med Wochenschr; 1979 Jun; 109(22):860-1. PubMed ID: 462160
[TBL] [Abstract][Full Text] [Related]
3. [Pathological variability and cancer treatment in lung cancer].
Kodama T
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2708-17. PubMed ID: 3019250
[TBL] [Abstract][Full Text] [Related]
4. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
Watanabe Y; Sato H; Iida S; Yamada T; Kobayashi H; Kimoto H; Tsunamura Y; Ichihashi T; Shimizu J; Hashizume Y
Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515
[TBL] [Abstract][Full Text] [Related]
5. Non-specific immunostimulation in bronchogenic cancer.
Israel L
Scand J Respir Dis Suppl; 1974; 89():95-105. PubMed ID: 4370224
[No Abstract] [Full Text] [Related]
6. [Hematological observations in patients following immunostimulation through intrapleural application of Corynebacterium parvum].
Karrer K; Denck H; Pridun N
Acta Med Austriaca; 1979; 6(5):209-12. PubMed ID: 233458
[TBL] [Abstract][Full Text] [Related]
7. Combination chemoimmunotherapy for extensive non-oat cell lung cancer.
Issell BF; Valdivieso M; Hersh EM; Richman S; Gutterman JU; Bodey GP
Cancer Treat Rep; 1978 Jul; 62(7):1059-63. PubMed ID: 356968
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
[TBL] [Abstract][Full Text] [Related]
9. [Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].
Fujisawa T; Yamaguchi Y
Gan No Rinsho; 1983 Oct; 29(12):1409-16. PubMed ID: 6315989
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors in lung cancer based on Shanghai population].
Liao ML; Gao YT; Yang ZP
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(1):36-8, 63-4. PubMed ID: 8403060
[TBL] [Abstract][Full Text] [Related]
11. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
[TBL] [Abstract][Full Text] [Related]
12. [Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].
Fujisawa T
Gan To Kagaku Ryoho; 1985 Jan; 12(1):13-20. PubMed ID: 2981513
[TBL] [Abstract][Full Text] [Related]
13. [Surgery and adjuvant therapy of non-small cell lung cancer].
Watanabe Y; Yamada T; Ichihashi T; Hashizume Y; Iwa T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1534-46. PubMed ID: 3524465
[TBL] [Abstract][Full Text] [Related]
14. Intrapleural and intravenous Corynebacterium parvum in patients with resected stage I and II non-small cell carcinoma of the lung. The Ludwig Lung Cancer Study Group.
Ludwig Lung Cancer Study Group
Cancer Immunol Immunother; 1986; 23(1):1-4. PubMed ID: 2876772
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C
Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
[TBL] [Abstract][Full Text] [Related]
16. [Surgical therapeutic planning for non-small cell lung cancer].
Sawamura K; Mori T; Hashimoto S; Iuchi K; Tada H; Lee YE; Mizuta T; Ichimiya A; Akashi A
Gan To Kagaku Ryoho; 1985 Jan; 12(1):36-44. PubMed ID: 2981516
[TBL] [Abstract][Full Text] [Related]
17. The surgical treatment of lung cancer: a retrospective analysis of 2004 cases.
Zhang D; Zhang R; Cheng G
Chin Med J (Engl); 1999 Jan; 112(1):25-8. PubMed ID: 11593634
[TBL] [Abstract][Full Text] [Related]
18. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer.
Ferguson MK; Little AG; Golomb HM; Hoffman PC; DeMeester TR; Beveridge R; Skinner DB
J Thorac Cardiovasc Surg; 1986 Mar; 91(3):344-9. PubMed ID: 3005776
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
20. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
